EMA Authorised: Delstrigo (doravirine;lamivudine;tenofovir disoproxil fumarate) — Merck Sharp & Dohme B.V.

View source ↗

Summary

EMA authorised Delstrigo, a fixed-dose combination tablet of doravirine, lamivudine and tenofovir disoproxil fumarate, for HIV infections. The marketing authori…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• DELSTRIGO (DORAVIRINE, LAMIVUDINE, TENOFOVIR DISOPROXIL FUMARATE)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Merck Sharp & Dohme B.V.. Decision date: 16/10/2025